Search

Showing "11155" results for ""

CROI: Nanoparticle technology creates a once-a-month HIV drug

CROI: Three children in US infected with HIV from pre-chewed food

CROI: Risk of second virological failure has declined since 1996, but risk of death remains stable

CROI: Herpes virus suppression with valaciclovir lowers viral load in HIV positive women: could work for gay men too

CROI: Large cohorts show excellent responses to ART in developing countries

CROI: Once daily Kaletra tablets non-inferior to twice daily dose

CROI: Risk of lymphomas depends on cumulative viral load and latest CD4 counts

CROI: Tenofovir plus emtricitabine safe and effective when added to nevirapine for PMTCT

CROI: HAART Breastfeeding study detects drug resistance in HIV-infected infants

CROI: Door-to-door Ugandan VCT programme finds more HIV-positive males than females among serodiscordant couples

CROI: MDR TB cases in South Africa - person-to-person spread likely to be chief cause

CROI: Tetherin: a newly discovered host cell protein that inhibits HIV replication

Reckless HIV transmission case dismissed due to insufficient evidence (amended)

CROI: Recreational drug use a risk for asymptomatic heart disorders in HIV-positive patients

FDA approves generic atazanavir

Boehringer-Ingelheim begins trial of once-daily extended release nevirapine

CROI: Region of origin and gender significant in long-term changes in CD4 cell count during effective HIV therapy

CROI: Married people should be primary target for HIV prevention in Uganda, national study shows

Receive the latest HIV research and conference news

Showing "11155" results for ""

CROI: Nanoparticle technology creates a once-a-month HIV drug

CROI: Three children in US infected with HIV from pre-chewed food

CROI: Risk of second virological failure has declined since 1996, but risk of death remains stable

CROI: Herpes virus suppression with valaciclovir lowers viral load in HIV positive women: could work for gay men too

CROI: Large cohorts show excellent responses to ART in developing countries

CROI: Once daily Kaletra tablets non-inferior to twice daily dose

CROI: Risk of lymphomas depends on cumulative viral load and latest CD4 counts

CROI: Tenofovir plus emtricitabine safe and effective when added to nevirapine for PMTCT

CROI: HAART Breastfeeding study detects drug resistance in HIV-infected infants

CROI: Door-to-door Ugandan VCT programme finds more HIV-positive males than females among serodiscordant couples

CROI: MDR TB cases in South Africa - person-to-person spread likely to be chief cause

CROI: Tetherin: a newly discovered host cell protein that inhibits HIV replication

Reckless HIV transmission case dismissed due to insufficient evidence (amended)

CROI: Recreational drug use a risk for asymptomatic heart disorders in HIV-positive patients

FDA approves generic atazanavir

Boehringer-Ingelheim begins trial of once-daily extended release nevirapine

CROI: Region of origin and gender significant in long-term changes in CD4 cell count during effective HIV therapy

CROI: Married people should be primary target for HIV prevention in Uganda, national study shows

Receive the latest HIV research and conference news